Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials

Stroke; a journal of cerebral circulation

Volumn 45, Issue 9, 2014, Pages 2728-2733

  Saver, Jeffrey L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

brain ischemia; cerebrovascular disorders; hemorrhage; stroke; thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

CEREBRAL HEMORRHAGE; CLINICAL TRIAL (TOPIC); FIBRINOLYTIC THERAPY; HUMAN; NATIONAL HEALTH ORGANIZATION; PROCEDURES; PROGNOSIS; RADIOGRAPHY; STANDARDS; STROKE; TREATMENT OUTCOME; UNITED STATES;

CEREBRAL HEMORRHAGE; CLINICAL TRIALS AS TOPIC; FIBRINOLYTIC AGENTS; HUMANS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; PROGNOSIS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UNITED STATES;

EID: 85027956509     PISSN: None     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005135     Document Type: Article

References (0)